Direct Rx recalls Lidocaine Ointment USP
- Recalling company
- Direct Rx
- Product
- Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
- Reason
- Subpotent Drug
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Sep 29, 2026
- Reported
- Nov 4, 2026
- Distribution
- Nationwide within the United States
- Status
- Ongoing
- Quantity
- 493 jars
- Lot / codes
- LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.
- Company location
- Dawsonville, GA
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0107-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0107-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.